Forbes January 14, 2025
Geri Stengel

“The WHAM Report: The Business Case for Accelerating Women’s Health Investment,” released today at the J.P. Morgan Healthcare Conference, reveals a paradigm shift in women’s healthcare. The report moves beyond reproductive health to highlight a vast, untapped market encompassing conditions that uniquely, disproportionately, or differently affect women, ranging from autoimmune diseases and Alzheimer’s to cardiovascular conditions. The growing recognition of women’s healthcare as a prime investment opportunity highlights the potential economic growth and health cost savings if VCs don’t invest. The report underscores a compelling case for investors to capitalize on this rapidly expanding market, driving innovation that addresses significant unmet needs and improves health outcomes for women globally.

“This is a largely untapped market with tremendous potential for return,”...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Survey / Study, Trends
Zoom invests in AI startup Suki
What's next for healthcare private equity?
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs
Private equity deal would set stage for 3-way Walgreens split: Report
Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M

Share This Article